Chemed (CHE) Accumulated Depreciation & Amortization (2016 - 2025)
Chemed (CHE) has 16 years of Accumulated Depreciation & Amortization data on record, last reported at $388.1 million in Q4 2025.
- For Q4 2025, Accumulated Depreciation & Amortization rose 1.6% year-over-year to $388.1 million; the TTM value through Dec 2025 reached $388.1 million, up 1.6%, while the annual FY2025 figure was $388.1 million, 1.6% up from the prior year.
- Accumulated Depreciation & Amortization reached $388.1 million in Q4 2025 per CHE's latest filing, up from $382.0 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $388.1 million in Q4 2025 and bottomed at $317.9 million in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $355.8 million, with a median of $354.9 million recorded in 2023.
- Peak YoY movement for Accumulated Depreciation & Amortization: grew 8.36% in 2021, then rose 1.6% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $317.9 million in 2021, then increased by 5.66% to $335.9 million in 2022, then rose by 5.64% to $354.9 million in 2023, then increased by 7.64% to $382.0 million in 2024, then rose by 1.6% to $388.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $388.1 million in Q4 2025, $382.0 million in Q4 2024, and $354.9 million in Q4 2023.